212 related articles for article (PubMed ID: 12012125)
21. Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.
Kreutz J; Vroonen L; Cattin F; Petrossians P; Thiry A; Rostomyan L; Tshibanda L; Beckers A; Bonneville JF
Neuroradiology; 2015 Jul; 57(7):679-84. PubMed ID: 25845810
[TBL] [Abstract][Full Text] [Related]
22. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
[TBL] [Abstract][Full Text] [Related]
23. Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment.
Saeki N; Nakamura M; Sunami K; Yamaura A
Endocr J; 1998 Aug; 45(4):529-37. PubMed ID: 9881903
[TBL] [Abstract][Full Text] [Related]
24. [Prolactin producing adenoma].
Tamaki N; Yonezawa K
Nihon Rinsho; 1993 Oct; 51(10):2685-90. PubMed ID: 8254940
[TBL] [Abstract][Full Text] [Related]
25. [Results of treatment for male prolactinomas].
Iwai Y; Yamanaka K; Ishiguro T; Morikawa T; Matsuzaka Y; Komiyama M; Yasui T
No Shinkei Geka; 2002 Dec; 30(12):1285-92. PubMed ID: 12491580
[TBL] [Abstract][Full Text] [Related]
26. Incidence and characteristics of microprolactinomas (3-5 mm) in 4199 women assayed for prolactin.
Batrinos ML; Panitsa-Faflia C; Tsiganou E; Liapi C
Horm Metab Res; 1992 Aug; 24(8):384-91. PubMed ID: 1526627
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
Katzir D; Rosenberg T; Ramot Y; Gaver-Shavit A; Gilboa Y
Harefuah; 1990 Feb; 118(3):141-5. PubMed ID: 2341064
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.
Chattopadhyay A; Bhansali A; Masoodi SR
Pituitary; 2005; 8(2):147-54. PubMed ID: 16379032
[TBL] [Abstract][Full Text] [Related]
29. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
30. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
[TBL] [Abstract][Full Text] [Related]
31. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902
[TBL] [Abstract][Full Text] [Related]
32. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
Yokoyama M
No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270
[TBL] [Abstract][Full Text] [Related]
33. Is a stable or decreasing prolactin level in a patient with prolactinoma a surrogate marker for lack of tumor growth?
Alkabbani AG; Mon SY; Hatipoglu B; Kennedy L; Faiman C; Weil RJ; Hamrahian AH
Pituitary; 2014 Apr; 17(2):97-102. PubMed ID: 23468127
[TBL] [Abstract][Full Text] [Related]
34. Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.
Brue T; Pellegrini I; Gunz G; Morange I; Dewailly D; Brownell J; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 1992 Mar; 74(3):577-84. PubMed ID: 1346788
[TBL] [Abstract][Full Text] [Related]
35. Growth potential of prolactinomas in men: is it really different from women?
Nishioka H; Haraoka J; Akada K
Surg Neurol; 2003 May; 59(5):386-90; discussion 390-1. PubMed ID: 12765811
[TBL] [Abstract][Full Text] [Related]
36. Prolactin-secreting tumors: what's new?
Molitch ME
Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S29-35. PubMed ID: 17004854
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathology, clonality, and hormone production profile of prolactinoma].
Ma WB; Ikeda H; Yoshimoto T
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1382-7. PubMed ID: 16029648
[TBL] [Abstract][Full Text] [Related]
38. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
[TBL] [Abstract][Full Text] [Related]
39. The value of pituitary magnetic resonance imaging in men with hypogonadism.
Rhoden EL; Estrada C; Levine L; Morgentaler A
J Urol; 2003 Sep; 170(3):795-8. PubMed ID: 12913700
[TBL] [Abstract][Full Text] [Related]
40. Necrotic changes in prolactinomas after long term administration of bromocriptine.
Gen M; Uozumi T; Ohta M; Ito A; Kajiwara H; Mori S
J Clin Endocrinol Metab; 1984 Sep; 59(3):463-70. PubMed ID: 6746860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
